Literature DB >> 19106070

The role of innate immunity in atherogenesis.

Karsten Hartvigsen1, Meng-Yun Chou, Lotte F Hansen, Peter X Shaw, Sotirios Tsimikas, Christoph J Binder, Joseph L Witztum.   

Abstract

Lipid peroxidation is a common event in health and is greatly accelerated in pro-inflammatory settings such as hypercholesterolemia. Consequently, oxidation-specific epitopes are generated, which are pro-inflammatory and immunogenic, leading to both adaptive and innate responses. Because innate immune mechanisms use conserved germline pattern recognition receptors (PRRs) that are preformed and present at birth, it is not obvious why they should bind to such epitopes. In this review, we put forward the hypothesis that because oxidation-specific epitopes are ubiquitous in both health and disease, and because they in essence represent "danger signals," they constitute a class of pathogen-associated molecular patterns leading to the natural selection of multiple innate PRRs that target such epitopes. We suggest that apoptotic cells, and the blebs and microparticles released from such cells, which are rich in oxidation-specific epitopes and thus pro-inflammatory, constitute an endogenous set of selecting antigens. In turn, natural antibodies, scavenger receptors, and soluble innate proteins, such as pentraxins, all represent PRRs that target such epitopes. We discuss the evidence for this hypothesis and the consequences of such responses in health and disease, such as atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19106070      PMCID: PMC2674727          DOI: 10.1194/jlr.R800100-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  51 in total

1.  Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation.

Authors:  Peter Friedman; Sohvi Horkko; Daniel Steinberg; Joseph L Witztum; Edward A Dennis
Journal:  J Biol Chem       Date:  2001-12-14       Impact factor: 5.157

2.  Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions.

Authors:  Joakim Huber; Anja Vales; Goran Mitulovic; Michael Blumer; Rainer Schmid; Joseph L Witztum; Bernd R Binder; Norbert Leitinger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-01       Impact factor: 8.311

3.  Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein.

Authors:  K Gillotte-Taylor; A Boullier; J L Witztum; D Steinberg; O Quehenberger
Journal:  J Lipid Res       Date:  2001-09       Impact factor: 5.922

4.  Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse.

Authors:  Q S Mi; L Zhou; D H Schulze; R T Fischer; A Lustig; L J Rezanka; D M Donovan; D L Longo; J J Kenny
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity.

Authors:  P X Shaw; S Hörkkö; M K Chang; L K Curtiss; W Palinski; G J Silverman; J L Witztum
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

6.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.

Authors:  Mi-Kyung Chang; Christoph J Binder; Michael Torzewski; Joseph L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

7.  Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease.

Authors:  Rika Dei; Akinori Takeda; Hisayoshi Niwa; Mei Li; Yuji Nakagomi; Masaki Watanabe; Toshiaki Inagaki; Yukihiko Washimi; Yoshinari Yasuda; Katsunori Horie; Toshio Miyata; Gen Sobue
Journal:  Acta Neuropathol       Date:  2002-06-04       Impact factor: 17.088

8.  Infectious agents are not necessary for murine atherogenesis.

Authors:  S D Wright; C Burton; M Hernandez; H Hassing; J Montenegro; S Mundt; S Patel; D J Card; A Hermanowski-Vosatka; J D Bergstrom; C P Sparrow; P A Detmers; Y S Chao
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

9.  Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells.

Authors:  Michael E Greenberg; Mingjiang Sun; Renliang Zhang; Maria Febbraio; Roy Silverstein; Stanley L Hazen
Journal:  J Exp Med       Date:  2006-11-13       Impact factor: 14.307

10.  C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction.

Authors:  M Griselli; J Herbert; W L Hutchinson; K M Taylor; M Sohail; T Krausz; M B Pepys
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

View more
  58 in total

1.  TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia.

Authors:  Sudipta Biswas; Alejandro Zimman; Detao Gao; Tatiana V Byzova; Eugene A Podrez
Journal:  Circ Res       Date:  2017-08-03       Impact factor: 17.367

Review 2.  Natural IgM antibodies against oxidation-specific epitopes.

Authors:  Christoph J Binder
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

3.  Fungal pathogen recognition by scavenger receptors in nematodes and mammals.

Authors:  Terry K Means
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

Review 4.  Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases.

Authors:  P Roux-Lombard; S Pagano; F Montecucco; N Satta; N Vuilleumier
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

Review 5.  Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.

Authors:  Adam Taleb; Joseph L Witztum; Sotirios Tsimikas
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 6.  Matricryptic sites control tissue injury responses in the cardiovascular system: relationships to pattern recognition receptor regulated events.

Authors:  George E Davis
Journal:  J Mol Cell Cardiol       Date:  2009-09-12       Impact factor: 5.000

Review 7.  Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases.

Authors:  Kuang-Yuh Chyu; Prediman K Shah
Journal:  Ther Adv Vaccines       Date:  2014-03

8.  A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK1.

Authors:  Shuhui Zheng; Lingli Long; Yonghao Li; Yuxia Xu; Zhang Jiqin; Weidong Ji; Wang Min
Journal:  Cardiovasc Pharm Open Access       Date:  2015-02-26

9.  Critical role of IL-17RA in immunopathology of influenza infection.

Authors:  Christopher R Crowe; Kong Chen; Derek A Pociask; John F Alcorn; Cameron Krivich; Richard I Enelow; Ted M Ross; Joseph L Witztum; Jay K Kolls
Journal:  J Immunol       Date:  2009-09-25       Impact factor: 5.422

10.  Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis.

Authors:  Andreas Hermansson; Daniel F J Ketelhuth; Daniela Strodthoff; Marion Wurm; Emil M Hansson; Antonino Nicoletti; Gabrielle Paulsson-Berne; Göran K Hansson
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.